Verrica Pharmaceuticals (VRCA) Other Non Operating Income (2022 - 2026)

Verrica Pharmaceuticals' Other Non Operating Income history runs 5 years deep, the most recent figure standing at -$8000.0 for Q1 2026.

• In Q1 2026, Other Non Operating Income fell 103.15% year-over-year to -$8000.0; the TTM figure through Mar 2026 stood at $3.2 million (up 235.98% YoY), while the FY2025 annual figure was $2.6 million, up 200.0% from the prior year.
• Other Non Operating Income for Q1 2026 stood at -$8000.0, down from $2.6 million in the prior quarter.
• The five-year high for Other Non Operating Income was $2.6 million in Q4 2025, with the low at -$2.6 million in Q4 2024.
• The 5-year median for Other Non Operating Income is -$5000.0 (2024), against an average of -$178909.1.
• The sharpest annual moves came in 2024 and 2025: Other Non Operating Income sank 5469.39% in 2024, then soared 12060.0% in 2025.
• Verrica Pharmaceuticals' Other Non Operating Income stood at -$1.4 million in 2022, then jumped by 103.54% to $49000.0 in 2023, then tumbled by 5469.39% to -$2.6 million in 2024, then soared by 200.68% to $2.6 million in 2025, then tumbled by 100.3% to -$8000.0 in 2026.
• Business Quant data shows VRCA's Other Non Operating Income at -$8000.0 in Q1 2026, $2.6 million in Q4 2025, and $598000.0 in Q2 2025.